Skip to ContentSkip to Navigation
About us Latest news News News articles

Marker discovery for response to (chemo) radiation and prognosis in cervical cancer

17 January 2011

PhD ceremony: Ms. M.G. Noordhuis, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen

Title: Marker discovery for response to (chemo) radiation and prognosis in cervical cancer

Promotor(s): prof. A.G.J. van der Zee, prof. H. Hollema, prof. G. de Bock

Faculty: Medical Sciences

 

Cervical cancer is, after breast and colorectal cancer, the most common cancer among women. According to the stage of the disease patients are treated surgically (early stage) or with chemoradiation (advanced stage). The 5-year survival rate of patients treated with chemoradiation is 66%. Treatment is generally based on well-known clinicopathologic factors, such as disease stage and tissue examination. The aim of this thesis was to identify cell biological markers and pathways associated with pelvic lymph node metastasis, response to (chemo)radiation, and prognosis in cervical cancer.

The thesis provides validated insights in the molecular mechanism of lymph node metastases. In a large series of early stage cervical cancer patients, two pathways (TGF-β and the p120-associated β-catenin pathway) were associated with absence and presence of pelvic lymph node metastases, respectively. Positive PTEN immunostaining (member of EGFR-pathway) was also associated with absence of lymph node metastases. In addition, in a large series of advanced stage cervical cancer patients who were treated with (chemo)radiation, the EGFR-pathway and phosphorylated ATM were discovered as independent predictors of poor response to chemoradiation and poor survival. The results of this thesis may contribute to a better prediction of pelvic lymph node metastases and response to chemoradiation. Ideally, therapeutic targeting these pathways may lead to improved survival of cervical cancer patients.

 

 

Last modified:13 March 2020 01.11 a.m.
View this page in: Nederlands

More news

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.

  • 10 June 2024

    Swarming around a skyscraper

    Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...